The interaction of calcium and cAMP and the relationship to ventricular vulnerability.
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003326:Coronary Circulation; D000242:Cyclic AMP / Q000378:metabolism*; D004110:Diltiazem / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology; D051381:Rats; D014693:Ventricular Fibrillation / Q000378:metabolism* / Q000503:physiopathology; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D014700:Verapamil; D000242:Cyclic AMP; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium; D004837:Epinephrine